LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Fructose Ingestion Stimulates Hormone Leading to Fructose Tolerance Test

By LabMedica International staff writers
Posted on 04 Nov 2014
Print article
Biovendor\'s enzyme-linked immunosorbent assay kit for measuring protein markers
Enzyme-linked immunosorbent assay kit for measuring protein markers (Photo courtesy of BIOVENDOR Group)
The determination of the body's metabolic response to fructose has been very difficult, and consequently, there is no fructose tolerance test to warn of impaired or altered fructose metabolism.

Fibroblast growth factor 21 (FGF21) is a recently discovered hormone produced primarily by key metabolic tissues including the liver and adipose tissue which has pleiotropic actions on glucose and lipid homeostasis and theoretically fructose ingestion might acutely stimulate production of FGF21.

Endocrinologists at the Beth Israel Deaconess Medical Center (Boston, MA, USA) recruited 10 lean, healthy study subjects and 11 patients with metabolic syndrome. They first tested the effect of glucose on FGF21 by giving volunteers a drink of 75 grams of glucose and measuring serum levels of glucose, cholesterol, and triglyceride levels which were analyzed over the course of five hours. Insulin samples were measured by radioimmunoassay (Millipore; Billerica, MA, USA). The study subjects were later given 75 grams of fructose or a combination of 37.5 grams of fructose and 37.5 grams of glucose dissolved in 225 mL water.

Serum FGF21 levels were measured using a commercially available enzyme-linked immunosorbent assay (BioVendor USA; Candler, NC, USA) from blood collected in aprotinin-pretreated tubes and were stored at -80 °C until use. Metabolic syndrome subjects had lower high-density lipoprotein (HDL) cholesterol, higher systolic blood pressure, and higher fasting and two-hour glycemia during an oral glucose tolerance test. However, after ingesting 75 grams of fructose, FGF21 levels dramatically increased by an average of 400% within only two hours.

Eleftheria Maratos-Flier, MD, a professor of Medicine and senior author of the study said, “This study tells us that fructose actively regulates FGF21 in humans. The hormone-like response of FGF21 to fructose ingestion suggests that FGF21 might play an unanticipated role in regulating fructose metabolism. We were totally surprised by this dramatic effect because, to date, there has been no way of assessing the body's acute metabolic response to fructose ingestion. We haven't had a simple quick test like we have for glucose.” The study was published on October 8, 2014, in the journal Molecular Metabolism.

Related Links:

Beth Israel Deaconess Medical Center
Millipore  
BioVendor USA  


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more